About Neos Therapeutics

United in our mission to improve the lives of patients and their families through innovation

At Neos Therapeutics, our team is dedicated to helping meet the needs of patients who struggle with ADHD and other CNS conditions.

Often, these patients need treatments that have complex medication delivery requirements. We develop, manufacture and commercialize innovative CNS products using our microparticle delivery technology to help meet the needs of these patients.

Our innovative technology enables the development of complex modified-release treatments and is used in our three approved ADHD products, generic tussionex and our growing development pipeline.

It is a powerful purpose to help improve the lives of patients, their families and caregivers. Our dedicated team of passionate science and business professionals is a compassionate collective force in advancing our mission to change the lives of patients. Every day, this focus on patients is our guiding principle to work to deliver our treatments into the hands of those in need.

Jerry McLaughlin, Chief Executive Officer